MiR-99b-5p expression and response to tyrosine kinase inhibitor treatment in clear cell renal cell carcinoma patients.
about
Serum miR-122-5p and miR-206 expression: non-invasive prognostic biomarkers for renal cell carcinoma.Potential clinical applications of microRNAs as biomarkers for renal cell carcinomamiR-9-5p in Nephrectomy Specimens is a Potential Predictor of Primary Resistance to First-Line Treatment with Tyrosine Kinase Inhibitors in Patients with Metastatic Renal Cell Carcinoma
P2860
MiR-99b-5p expression and response to tyrosine kinase inhibitor treatment in clear cell renal cell carcinoma patients.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
MiR-99b-5p expression and resp ...... renal cell carcinoma patients.
@en
MiR-99b-5p expression and resp ...... renal cell carcinoma patients.
@nl
type
label
MiR-99b-5p expression and resp ...... renal cell carcinoma patients.
@en
MiR-99b-5p expression and resp ...... renal cell carcinoma patients.
@nl
prefLabel
MiR-99b-5p expression and resp ...... renal cell carcinoma patients.
@en
MiR-99b-5p expression and resp ...... renal cell carcinoma patients.
@nl
P2093
P2860
P50
P356
P1433
P1476
MiR-99b-5p expression and resp ...... renal cell carcinoma patients
@en
P2093
Arnulf Stenzl
Axel Mischo
Christiane Mittmann
Christoph Karlo
Holger Moch
Iris Blume
Jörg Hennenlotter
Magdalena Lukamowicz-Rajska
Manuela Schmidinger
Peter Schraml
P2860
P304
78433-78447
P356
10.18632/ONCOTARGET.12618
P407
P577
2016-11-01T00:00:00Z